|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
PharmaCorp
|
|
gptkbp:awards
|
Best_Biotech_Company_2022
|
|
gptkbp:CEO
|
gptkb:John_Doe
|
|
gptkbp:clinicalTrials
|
Cardiology
Immunology
Oncology
Ongoing
Neurology
|
|
gptkbp:collaborations
|
gptkb:Harvard_University
gptkb:Stanford_University
gptkb:University_of_Cambridge
gptkb:MIT
|
|
gptkbp:communityEngagement
|
Educational programs
Scholarships
Health fairs
Local health initiatives
Volunteer_work
|
|
gptkbp:employees
|
500
|
|
gptkbp:financials
|
Research grants
Educational institutions
Health organizations
Community projects
Non-profits
|
|
gptkbp:focusArea
|
Rare diseases
|
|
gptkbp:foundedIn
|
2000
|
|
gptkbp:founder
|
Jane_Smith
|
|
gptkbp:hasCompetitors
|
gptkb:GeneTech
gptkb:BioPharma_Inc.
gptkb:MediGene
CellBio
TheraGen
|
|
gptkbp:headCoach
|
500+
|
|
gptkbp:headquarteredIn
|
gptkb:Cambridge,_Massachusetts
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
BioGen Solutions
|
|
gptkbp:industry
|
Biotechnology
|
|
gptkbp:investmentFocus
|
Venture_Capital_Firms
|
|
gptkbp:market
|
$1 billion
|
|
gptkbp:mission
|
Innovate in gene therapy
|
|
gptkbp:partnerships
|
Research institutions
|
|
gptkbp:patentCitation
|
50+
|
|
gptkbp:products
|
Gene therapies
|
|
gptkbp:researchAndDevelopment
|
Yes
|
|
gptkbp:researchFocus
|
CRISPR technology
|
|
gptkbp:revenue
|
$200 million
|
|
gptkbp:services
|
Biopharmaceutical development
|
|
gptkbp:subsidiary
|
gptkb:BioGen_Therapeutics
|
|
gptkbp:sustainabilityInitiatives
|
Recycling programs
Waste reduction programs
Green energy usage
Sustainable sourcing
|
|
gptkbp:vision
|
Transform lives through biotechnology
|
|
gptkbp:website
|
www.biogensolutions.com
|